Alcon Dodges FCA Suit Over Eye Drug Marketing

Law360, New York (August 27, 2013, 7:28 PM EDT) -- A former Alcon Laboratories Inc. employee on Monday dropped a whistleblower lawsuit alleging the pharmaceutical company violated the False Claims Act by marketing eye drugs off-label, after the federal government refused to take up the case.

Former Alcon employee Michael Jackson had claimed that the company used improper incentives to push doctors to prescribe the drugs Vigamox and Nevanac, which can be used to treat certain eye conditions.

Jackson, a former Alcon sales representative, filed his suit against the Texas-based company under seal in October 2009,...
To view the full article, register now.




Case Information

Case Title

United States of America et al v. Alcon Laboratories, Inc.

Case Number



Georgia Northern

Nature of Suit

Fraud or Truth-In-Lending


Thomas W. Thrash, Jr

Date Filed

October 2, 2009

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.